Literature DB >> 2498273

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

M Inukai1, F Isono, S Takahashi, R Enokita, Y Sakaida, T Haneishi.   

Abstract

A strain of actinomycetes identified as Streptomyces flavidovirens produced new antibiotics, mureidomycins (MRD's) A approximately D, specifically active against Pseudomonas aeruginosa. They were isolated from the culture filtrate by successive column chromatographies such as Amberlite XAD-2 and CG-50, Whatman DE-52 and Toyopearl HW-40. They were amphoteric white powders and soluble in methanol and water. Their molecular weights and molecular formulae in parentheses were 840 (C38H48N8O12S), 842 (C38H50N12S), 897 (C40H51N9O13S) and 899 (C40H53N9O13S), respectively. m-Tyrosine and two unknown substances were detected by amino acid analyses as their common constituents. MRD's A and C contained uracil but MRD's B and D dihydrouracil instead of uracil.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498273     DOI: 10.7164/antibiotics.42.662

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library.

Authors:  Dianqing Sun; Victoria Jones; Elizabeth I Carson; Robin E B Lee; Michael S Scherman; Michael R McNeil; Richard E Lee
Journal:  Bioorg Med Chem Lett       Date:  2007-10-04       Impact factor: 2.823

Review 2.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.

Authors:  P E Brandish; K I Kimura; M Inukai; R Southgate; J T Lonsdale; T D Bugg
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

4.  Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis.

Authors:  F Isono; M Inukai
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 5.  Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.

Authors:  Ellene H Mashalidis; Seok-Yong Lee
Journal:  J Mol Biol       Date:  2020-03-19       Impact factor: 5.469

6.  Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins.

Authors:  F Isono; K Kodama; M Inukai
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins.

Authors:  M Inukai; F Isono; A Takatsuki
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 8.  Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.

Authors:  M McErlean; X Liu; Z Cui; B Gust; S G Van Lanen
Journal:  Nat Prod Rep       Date:  2021-07-21       Impact factor: 15.111

9.  Identification of novel mureidomycin analogues via rational activation of a cryptic gene cluster in Streptomyces roseosporus NRRL 15998.

Authors:  Lingjuan Jiang; Lu Wang; Jihui Zhang; Hao Liu; Bin Hong; Huarong Tan; Guoqing Niu
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

10.  Molecular mechanism of mureidomycin biosynthesis activated by introduction of an exogenous regulatory gene ssaA into Streptomyces roseosporus.

Authors:  Ning Liu; Hanye Guan; Guoqing Niu; Lingjuan Jiang; Yue Li; Jihui Zhang; Jine Li; Huarong Tan
Journal:  Sci China Life Sci       Date:  2021-02-09       Impact factor: 6.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.